With
Brett J. Bromann,
Mhairi C. Immermann,
Steven D. Singer
Agios Pharmaceuticals, Inc. announced the closing of its previously announced underwritten public offering of common stock, including the exercise in full by the underwriters of their option...
With
Meredith Cross,
Douglas J. Davison,
Knute Salhus
On September 10, 2014, the Securities and Exchange Commission (SEC) announced charges against 28 officers, directors, and major stockholders of public companies for violating Section 16(a) and/or Section 13(d) of the Securities Exchange Act of 1934, as amended (the Exchange Act).
With
Meredith Cross,
Douglas J. Davison,
Michael Mugmon,
Knute Salhus,
Jonathan Wolfman,
Joseph Wyatt
On September 10, 2014, the Securities and Exchange Commission (SEC) announced charges against 28 officers, directors and major stockholders of public companies for violating Section 16(a) and/or Section 13(d) of the Securities Exchange Act of 1934, as amended (the Exchange Act).
